10-K: Kodak Navigates Market Shifts, Boosts Advanced Materials Amidst Debt Refinements

Sentiment:

Annual Report


Eastman Kodak Company reports a modest revenue increase in 2025, driven by Advanced Materials and Chemicals, while its Print segment faces volume declines and strategic debt amendments reshape its financial structure.

Capital raiseOn May 21, 2025, the Company entered into an ATM Equity Offering Sales Agreement with BofA Securities, Inc., allowing it to offer and sell up to $100 million of common stock.During 2025, the Company sold 200,000 shares for net proceeds of approximately $1 million under this program.The company may desire to raise additional capital to support ongoing operations, pursue growth opportunities, strategic transactions, or refinance/redeem outstanding debt or preferred stock.
Worse than expectedNet loss of $128 million in 2025 compared to net earnings of $102 million in 2024.Significant excise tax payment of $153 million on KRIP reversion asset surplus.Impairment charges of $22 million on the investment in Wildcat Discovery Technologies, Inc.Print segment revenues declined by 3% ($22 million).Pension income decreased by $45 million.

Summary

  • Consolidated revenues increased by $26 million (2%) to $1.069 billion in 2025.
  • Print segment revenues declined by $22 million (3%) in 2025, primarily due to reduced volumes in Prepress Solutions ($40 million), Electrophotographic Printing Solutions (EPS) ($16 million), Prosper ($4 million), and Software ($2 million).
  • Advanced Materials and Chemicals segment revenue improved by $45 million (17%) in 2025, driven by improved pricing and volume increases.
  • Brand segment revenues improved by $3 million due to higher volumes.
  • Gross profit increased by $29 million in 2025, primarily due to improved pricing in Print ($27 million) and Advanced Materials and Chemicals ($24 million).
  • A net loss of $128 million was recorded in 2025, compared to net earnings of $102 million in 2024, largely due to a $153 million excise tax on KRIP reversion and $22 million impairment charges on the Wildcat investment.
  • Net cash provided by operating activities was $480 million in 2025, a significant increase from a $7 million usage in 2024, primarily due to $618 million cash proceeds from the Kodak Retirement Income Plan (KRIP) asset reversion.
  • Restructuring actions in 2025 resulted in $21 million in charges, expected to generate $23 million in annual cash savings by the end of 2026.
  • The company repaid $306 million of Term Loans in 2025 using KRIP reversion cash proceeds.
  • Series B Preferred Stock dividend rate increased from 4.0% to 6.0% per annum, and its mandatory redemption date was extended to June 11, 2029.
  • Mandatory conversion triggers for Series B Preferred Stock were introduced at $14.50, $15.50, and $16.50 common stock prices after 18, 24, and 30 months from March 11, 2026, respectively.
  • The Term Loan Credit Agreement was amended to require $50 million prepayments by March 18, 2026, and another $50 million by June 1, 2026, each with a 1% prepayment fee.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed filing. While strategic initiatives in advanced materials and significant cash generation from pension asset reversion are positive, the substantial net loss, declining print revenues, and new debt prepayment obligations indicate ongoing financial challenges and a need for sustained operational improvement.

Positives

  • Consolidated revenues increased by 2% to $1.069 billion in 2025.
  • Advanced Materials and Chemicals segment revenue grew by 17% ($45 million) in 2025, indicating successful diversification and growth in new initiatives.
  • Gross profit increased by $29 million in 2025, reflecting improved pricing strategies.
  • Net cash provided by operating activities significantly improved to $480 million in 2025 from a $7 million usage in 2024, largely due to the KRIP asset reversion.
  • Successful termination of the Kodak Retirement Income Plan (KRIP) and reversion of $1.023 billion in excess pension assets, providing $618 million in cash and $158 million in investment assets to the company.
  • Restructuring actions in 2025 are expected to generate $23 million in annual cash savings by the end of 2026, enhancing future profitability.
  • Launch of Kodak's own direct distribution brand of still films in Q4 2025, aiming for more stable pricing and reliable supply.
  • Completion of the Current Good Manufacturing Practice (cGMP) lab and manufacturing facility at Eastman Business Park (EBP) in 2025, certified for healthcare reagent manufacturing, opening new market opportunities.
  • Successful exchange of all Series C Preferred Stock for common stock, simplifying the capital structure and fully discharging related obligations.
  • Removal of the mandatory redemption of Series B Preferred Stock as a basis for accelerating Term Loan maturity, providing greater debt stability.
  • Elimination of the mandatory prepayment obligation requiring Kodak to use 50% of net cash proceeds from certain transactions to prepay Term Loans below $200 million.
  • The company believes its liquidity position is adequate to fund operations and meet obligations for the next twelve months.

Negatives

  • A net loss of $128 million was reported in 2025, contrasting with net earnings of $102 million in 2024.
  • Print segment revenues declined by 3% ($22 million) in 2025, indicating ongoing challenges in a core business area.
  • A significant excise tax payment of $153 million was made on the KRIP reversion asset surplus, impacting net earnings.
  • Impairment charges of $22 million were recorded on the investment in Wildcat Discovery Technologies, Inc. during 2025.
  • Higher manufacturing costs ($11 million in Print, $7 million in Advanced Materials and Chemicals) and aluminum costs ($9 million) impacted gross profit in 2025.
  • Interest expense increased by $3 million in 2025, primarily due to higher debt discount amortization.
  • A loss on early extinguishment of debt of $7 million was recorded in Q4 2025.
  • Pension income decreased by $45 million in 2025 compared to 2024.
  • Ongoing challenges from higher raw material and other supply chain costs, competitive pricing pressures, and volume declines persist in the Print segment.
  • Labor shortages were experienced in certain manufacturing areas of the Advanced Materials and Chemicals segment.
  • Increased competition in the U.S. from low-priced plates imported from China and Japan continues, despite anti-dumping/countervailing duties.
  • Direct operations of the Russian subsidiary have ceased and are being wound down due to geopolitical events.
  • The Series B Preferred Stock dividend rate increased from 4.0% to 6.0% per annum, increasing dividend costs.
  • Mandatory prepayments of $100 million on Term Loans are required by June 1, 2026, with a 1% fee, impacting immediate liquidity.

Risks

  • Global economic and geopolitical conditions (wars in Ukraine and Iran, conflicts involving Israel, inflation, commodity prices, interest rates, trade policies, customer demand volatility) may adversely affect business, financial condition, and results of operations.
  • Inability to generate positive operating cash flows consistently or supplement with financing/monetization transactions could impair or limit the ability to continue as a going concern.
  • Failure to successfully develop, fund, and commercialize products in focused businesses (print, advanced materials, chemicals) or do so within an acceptable timeframe.
  • Inability to successfully or timely implement cost structure reductions, leading to lost sales, weakened customer relationships, lower employee morale, loss of key personnel, product delays, and increased costs.
  • Loss of key personnel or failure to attract and retain other highly qualified personnel in the future.
  • Inability to effectively anticipate or rapidly respond to technology trends or develop and market new products that meet changing customer needs.
  • Increased competition, including price competition, could materially adversely affect revenue, gross margins, cash flow, and market share.
  • Exposure to risks associated with expanding into related or new markets and industries.
  • New products and services may not achieve expected returns or profitability.
  • Failure to manage product reliability, yield, and quality, potentially leading to delayed launches, increased costs, lost revenue, and reputational harm.
  • Aging manufacturing facilities and equipment could lead to failures and require significant capital investment.
  • Failure to manage distribution of products and services properly.
  • Inability to protect intellectual property rights or claims of infringement by third parties.
  • Cyber-attacks or other data security incidents that disrupt operations or result in the breach or compromise of proprietary or confidential information.
  • Failure to successfully manage the development and improvement of IT systems.
  • Emerging issues related to the development and use of artificial intelligence ('AI') could give rise to legal or regulatory action, damage reputation, or otherwise materially harm business.
  • Inability to effectively complete and manage strategic transactions (investments, acquisitions, strategic alliances, joint ventures, divestitures).
  • Erosion of Kodak's or its brand's reputation.
  • Business disruptions (extreme weather events, natural disasters, infrastructure failures, power/telecommunications outages, epidemics, political/economic instability).
  • Reliance on third-party suppliers and service providers.
  • Exposure to fluctuations in foreign currency exchange rates, interest rates, and commodity costs, and impacts of changes in trade policies.
  • Additional costs and risks associated with worldwide business operations.
  • Inability to provide competitive financing arrangements to customers or extension of credit to customers whose creditworthiness deteriorates.
  • Substantial monetary obligations requiring a portion of cash flow to be used for other obligations rather than invested in the business.
  • Limited availability of letters of credit under the Amended and Restated L/C Facility Agreement due to cash collateral requirements.
  • Limited access to additional capital funding due to non-investment grade credit rating and/or current volatility and tightening in financial and credit markets.
  • Inability to comply with the terms of various credit facilities, potentially resulting in an event of default.
  • Current non-investment grade status may adversely impact commercial operations, increase liquidity requirements, and increase the cost of refinancing opportunities.
  • Legal proceedings and governmental investigations could materially adversely affect operations and prospects, reputation, financial condition, results of operations, and stock price.
  • Improper conduct by employees, agents, distributors, or others perceived as acting on behalf of Kodak.
  • Failure to comply with privacy, data protection, and cybersecurity laws and regulations.
  • Failure to effectively manage sustainability-related expectations.
  • Failure to maintain effective internal controls over financial reporting.
  • Additional tax liabilities due to complex and evolving tax laws.
  • Future pension and other postretirement benefit plan costs and required contributions could increase.
  • Impairments in the value of trade name and/or other long-lived assets.
  • Conversion of the Series B Preferred Stock into shares of common stock may dilute the value for current holders.
  • Resale of a large portion of outstanding securities, or the perception of such resale, may adversely affect the price of common stock.
  • Certain accumulations or transfers of outstanding securities could result in a change of control and the loss of favorable tax attributes.
  • Stock price has been and may continue to be volatile.

Future Outlook

Kodak plans to focus product investment in core competency areas of advanced materials and print, leveraging proprietary technologies. It aims to promote film use and expand applications, while continuing to invest in automation and streamline processes to drive cost reductions and operating efficiencies. The company expects to generate profitable revenues through continued pricing actions and customer-focused initiatives, invest in new product innovation to drive growth, implement effective working capital utilization, reduce operating expenses, simplify the organizational structure, invest in IT systems to drive operational efficiencies, effectively manage world-wide cash through intercompany loans, distributions or other mechanisms, generate cash from selling and leasing underutilized assets or through new licensing opportunities and implement ways to reduce cash collateral needs. The company believes its liquidity position is adequate to fund operations and meet its obligations for the next twelve months.

Management Comments

  • "Kodak believes in the power of technology and science to enhance what the world sees and creates."
  • "Kodak's innovative, award-winning products, combined with its customer-first approach, make us the partner of choice for commercial printers worldwide."
  • "Kodak is committed to environmental stewardship, including industry leadership in developing sustainable solutions for print."
  • "Kodak believes its liquidity position is adequate to fund operations, meet its obligations and provide the flexibility to respond as necessary to ordinary changes in the business and economic environment within twelve months as of the filing of this Form 10-K."

Industry Context

StockSavvy.ai notes that Kodak operates in industries facing significant competition from digital substitution, particularly in print and film. The company's strategy to leverage its deep expertise in chemistry and coating processes for new initiatives like EV/energy storage battery materials and pharmaceuticals aligns with broader trends in advanced manufacturing and healthcare. The challenges from higher raw material costs, competitive pricing, and volume declines in print reflect ongoing pressures across traditional manufacturing sectors, while the focus on sustainable print solutions addresses increasing environmental demands in the commercial printing industry. The anti-dumping duties on imported plates from China and Japan highlight global trade tensions and their impact on specific manufacturing segments.

Comparison to Industry Standards

  • Kodak's focus on KODAK SONORA Process Free Plates for environmental sustainability aligns with a growing industry trend towards greener printing solutions, offering cost savings and efficiency for customers.
  • The development of PROSPER ULTRA 520 Press, powered by ULTRASTREAM inkjet technology, aims to deliver exceptional quality at high speeds, positioning Kodak against competitors like HP, Canon, Ricoh, and Screen in the high-quality digital printing market.
  • Kodak's expansion into manufacturing Diagnostic Test Reagent solutions and coated substrates for EV/energy storage batteries leverages its chemical manufacturing expertise, entering high-growth sectors that are attracting significant investment and innovation globally.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive Chairman and Chief Executive OfficerNAJames V. ContinenzaJanuary 1, 2026Renewal of employment agreement, superseding prior agreement.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Certificate of IncorporationAmended terms of Series B Preferred Stock, including dividend rate increase to 6.0% per annum, new mandatory redemption date of June 11, 2029, and mandatory conversion triggers based on common stock price.March 11, 2026Increases dividend cost for Series B Preferred Stock but provides clear pathways for mandatory conversion, potentially reducing preferred stock outstanding and simplifying capital structure over time. Requires consent for certain new debt.
Board Rights Agreement AmendmentKennedy Lewis Investment Management LLC's right to nominate one director continues as long as they hold at least $200 million of Term Loans or 50% of Series B Preferred Stock (including converted common stock).March 11, 2026Ensures continued influence of a significant lender/investor on the Board, aligning their interests with company governance.
Investor Rights AgreementKennedy Lewis Investment Management LLC granted preemptive rights for future equity issuances and the Company has rights of first refusal on transfers of Series B Preferred Stock by Kennedy Lewis.March 11, 2026Provides Kennedy Lewis with protection against dilution and gives the Company control over significant transfers of Series B Preferred Stock, potentially preventing undesirable ownership changes.
Beneficial Ownership Side Letter AmendmentAmended agreement with Kennedy Lewis Management LP and affiliated funds, setting a beneficial ownership limitation of 4.99% for common stock conversion, adjustable with 61 days' notice.March 11, 2026Manages potential ownership concentration and aims to avoid triggering certain regulatory thresholds or tax implications (e.g., Section 382 limitations).

Legal Proceedings

  • Kodak is involved in various litigation matters in Brazil, including governmental assessments related to indirect and other taxes, civil litigation, and disputes with former employees and contract labor. Accruals of approximately $5 million for claims aggregating $89 million as of December 31, 2025.
  • Kodak is disputing patent infringement claims brought by FUJIFILM Corporation in the US and Germany, alleging infringement by Kodak's SONORA process free plates on four patents in each jurisdiction.
  • Fuji appealed the ITC's material injury determination regarding imported aluminum lithographic printing plates, and the U.S. Court of International Trade remanded the determination for further analysis on February 18, 2026, though duty collection continues.
  • Kodak does not believe that the outcomes in these various matters, individually or collectively, will have a material adverse effect on its financial condition or results of operations.

Related Party Transactions

  • Kennedy Lewis Investment Management LLC (KLIM) and its affiliates are Term Loan Lenders and now hold all outstanding Series B Preferred Stock.
  • An affiliate of the Term Loan Lenders (KLIM) has the right to nominate one member for election to the Board.
  • The Series B Preferred Stock was purchased by KL Funds (affiliated with Kennedy Lewis) from previous Purchasers.
  • The Term Loan Credit Agreement and L/C Facility Agreement are with lenders affiliated with KLIM.
  • James V. Continenza's employment agreement includes a beneficial ownership limitation on stock option exercises to prevent exceeding 4.99% ownership with affiliates.

Stakeholder Impact

  • Shareholders face potential dilution from Series B Preferred Stock conversion, but also potential for increased value from strategic growth and debt reduction. Stock price volatility remains a risk.
  • Employees: Restructuring actions in 2025 led to the elimination of approximately 280 positions. A new Kodak Cash Balance Plan replaces KRIP, providing continued retirement benefits.
  • Customers benefit from continued focus on product innovation (e.g., SONORA Process Free Plates, ULTRASTREAM inkjet technology) and sustainability initiatives, but may be impacted by supply chain disruptions and pricing actions.
  • Creditors (Term Loan Lenders) are subject to mandatory prepayments on Term Loans and benefit from an increased Series B Preferred Stock dividend rate. KLIM, as a major lender and preferred shareholder, has significant governance rights.
  • Suppliers may experience impacts from supply chain constraints and the company's efforts to secure alternative suppliers.

Next Steps

  • Continue product investment in core competency areas of advanced materials and print.
  • Promote the use of film and expand applications of film and chemicals.
  • Continue to invest in automation and streamline processes to drive cost reductions and operating efficiencies.
  • Expand product offering in Pharmaceuticals business over time and apply for ISO 13485 certification.
  • Explore strategic alternatives to commercialize light-blocking technology.
  • Evaluate unique printing technology and expertise for transparent heaters in biomedical analytical devices and telecom applications.
  • Monitor events surrounding the war in Iran and other conflicts involving Israel and the impact on operations.
  • Continue to monitor the war in Ukraine and international response, and wind down the Russian subsidiary.
  • Repay $50 million of Term Loans by March 18, 2026, and another $50 million by June 1, 2026.
  • Receive an additional $55 million in cash proceeds from KRIP investment assets by December 31, 2026.
  • Convert remaining KRIP investment assets to cash primarily in 2027 and 2028.
  • Forecasted capital expenditures of $45 million to $55 million for 2026.
  • James V. Continenza's employment agreement extends to December 31, 2030, with annual RSU grants starting February 2027.

Key Dates

DateDescription
2019-01-31Kodak entered into a series of agreements with RED-Rochester, LLC.
2021-02-26Original Term Loan Credit Agreement, Securities Purchase Agreement, Series A Preferred Stock Repurchase and Exchange Agreement, Series C Preferred Stock Purchase Agreement, Series B Registration Rights Agreement, Letter of Credit Facility Agreement, and James V. Continenza's Executive Chairman and CEO Agreement were entered into.
2021-08-10Company filed a Registration Statement on Form S-3 (No. 254352) to register for possible resale of up to 44,490,032 shares of common stock.
2021-08-12Shelf Registration Statement on Form S-3 (No. 254353) originally declared effective.
2022-06-15Delayed draw term loans under the Original Term Loan Credit Agreement were drawn in full.
2023-06-30Term Loan Amendment to the Original Term Loan Credit Agreement and the June 2023 L/C Facility Amendment were entered into.
2023-07-21The Amended and Restated Term Loan Credit Agreement became effective, Term Loans were borrowed, the 2023 Amended ABL Credit Agreement was terminated, and Convertible Notes were repaid.
2023-08-01Company used $68 million from L/C Cash Collateral to cash collateralize workers' compensation obligations and reduced L/C Facility Commitments to $50 million.
2023-09-28Kodak filed petitions with the U.S. Department of Commerce and ITC regarding unfairly traded plates from China and Japan.
2023-11-15ITC made an affirmative preliminary determination on anti-dumping/countervailing duties for imported plates.
2023-11-29James V. Continenza's Employment Agreement was amended.
2024-03-14Mutual Non-Disclosure Agreement between Metropolitan Life Insurance Company, Insurer, and Company was dated.
2024-04-26Commerce Department announced preliminary findings in anti-dumping duty investigations on plates from China and Japan.
2024-05-28Commerce Department amended preliminary findings for plates from China.
2024-08-08Company filed a shelf Registration Statement on Form S-3 (No. 333-281403) for up to $500 million of securities.
2024-09-23Commerce Department announced final findings in anti-dumping duty investigations on plates from China and Japan and countervailing duty investigation on plates from China.
2024-10-22ITC made a final determination on material injury from imported plates from China and Japan.
2024-11-20Kodak Retirement Income Plan Trust entered into a Purchase and Sale Agreement with Mastercard Foundation for KRIP Illiquid Assets.
2024-12-31Trust sold KRIP Illiquid Assets for $510 million.
2025-01-01BEPS Pillar 2 rules became effective in numerous countries.
2025-01-21Board approved the termination of KRIP effective March 31, 2025.
2025-03-01Kodak Cash Balance Plan became effective for new hires.
2025-03-31KRIP termination became effective.
2025-04-01Kodak Cash Balance Plan became effective for current employees.
2025-05-07Second Amendment to Amended and Restated Term Loan Credit Agreement was entered into.
2025-05-21ATM Equity Offering Sales Agreement with BofA Securities, Inc. was entered into.
2025-07-01Company submitted a current actuarial report to the NYS WCB and requested a review of collateral requirements.
2025-07-04The One Big Beautiful Bill Act (OBBBA) was enacted in the U.S.
2025-08-08Series C Preferred Stock Exchange Agreement was entered into, the Series C Preferred Stock Exchange was consummated, and an Amended and Restated Registration Rights Agreement was entered into.
2025-10-01KRIP settled approximately $76 million of pension obligations through lump-sum payments to deferred vested participants.
2025-10-14Commitment Agreement Date for Metropolitan Tower Life Insurance Company.
2025-10-21Annuity obligations for KRIP annuitants were transferred to Metropolitan Tower Life Insurance Company.
2025-10-31KRIP settled approximately $157 million of pension obligations through lump-sum payments to active participants.
2025-11-04Third Amendment to Amended and Restated Credit Agreement and Amendment No. 4 to the Letter of Credit Facility Agreement were entered into.
2025-11-19David E. Bullwinkle terminated his Rule 10b5-1 Plan.
2025-11-26KRIP transferred its sole remaining liabilities for missing participants to the Pension Benefit Guaranty Corporation, and excess pension assets of $1.023 billion reverted to the Company (Reversion Date).
2025-11-28Company used $312 million of cash proceeds received from the Reversion Assets to repay outstanding Term Loans.
2025-12-05Certain funds affiliated with Kennedy Lewis (KL Funds) purchased all of the outstanding shares of Series B Preferred Stock from the Purchasers.
2025-12-18Roger W. Byrd terminated his Rule 10b5-1 Plan.
2025-12-30Kodak paid $153 million from the cash proceeds received from the Reversion Assets to satisfy the 20% excise tax on the remaining surplus.
2026-01-01James V. Continenza's Executive Chairman and CEO Agreement became effective.
2026-01-31Kodak received $44 million of additional cash proceeds from the redemption of a portion of KRIP investment assets.
2026-02-18The United States Court of International Trade remanded ITC's material injury determination regarding imported aluminum lithographic printing plates for further analysis and documentation.
2026-03-06The number of common shares outstanding was 97.5 million.
2026-03-11Effective Date of Registration Rights Agreement, Amended and Restated Board Rights Agreement, Investor Rights Agreement, and Letter Agreement (Beneficial Ownership Side Letter) with Kennedy Lewis. Certificate of Amendment to Second Amended and Restated Certificate of Incorporation filed, amending Series B Preferred Stock terms. Fourth Amendment to Amended and Restated Credit Agreement entered.
2026-03-12Audit report date.
2026-03-18Company is required to pay $50 million of the Term Loans.
2026-05-20Registrant's Annual Meeting of Shareholders to be held.
2026-06-01Company is required to pay $50 million of the Term Loans.
2026-12-31Majority of 2025 restructuring savings expected to take effect. Expected receipt of an additional $55 million in cash proceeds from KRIP investment assets.
2028-05-17Maturity date of the Amended and Restated L/C Facility Agreement.
2028-08-15Maturity date of the Term Loans.
2029-06-11New mandatory redemption date for Series B Preferred Stock.
2030-12-31Scheduled Term end for James V. Continenza's employment agreement.
2033-08-31RED-Rochester, LLC debt payments continue until this date.

Recommendation

hold

Eastman Kodak's 2025 performance presents a mixed picture. While the significant cash infusion from the KRIP pension asset reversion and strategic growth in Advanced Materials and Chemicals are positive, the company recorded a net loss due to one-time charges and continues to face revenue declines in its core Print segment. The recent debt amendments and Series B Preferred Stock changes provide some financial clarity and flexibility but also introduce new obligations. Given the ongoing operational challenges, geopolitical uncertainties, and the need for sustained execution of its growth strategy, a 'hold' recommendation is appropriate. Investors should monitor the company's ability to translate its strategic investments into consistent profitable growth and manage its debt obligations effectively.

Keywords

Eastman Kodak, KODK, SEC Filing, 10-K, Annual Report, Financial Performance, Print Industry, Advanced Materials, Chemicals, Brand Licensing, Pension Plan, Debt Restructuring, Series B Preferred Stock, Convertible Securities, Registration Rights, Cybersecurity, Supply Chain, Geopolitical Risk, AI, Sustainability, Intellectual Property, Commercial Printing, Digital Printing, Film Manufacturing, EV Battery Materials, Pharmaceuticals

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.